IBI-Ag Secures $6.1M in Series A to Pioneer Next-Gen Bio-Insecticides for Food Protection

IBI-Ag, an innovative Israeli-based company, has successfully raised $6,100,000 to advance its groundbreaking biocontrol solutions in the food protection and agricultural sectors.

Focused on addressing the persistent challenges of pest management, IBI-Ag is harnessing the power of a novel biological active ingredient paired with a new mode of action to develop a pioneering class of bio-insecticides.

This transformative funding injection is a testament to the confidence investors place in the company’s unique approach to precise and effective insect control.

By using its innovative biological solution, IBI-Ag is not only delivering a safer alternative to conventional chemical pesticides but is also ensuring minimal environmental impact.

The novel bio-insecticides are designed to target specific pests with unparalleled accuracy, offering growers and food producers robust protection while preserving essential ecosystem balances.

This targeted action minimizes collateral damage to beneficial insects and reduces the risk of pesticide resistance, marking a significant step forward in sustainable pest management.

The capital raised will allow IBI-Ag to accelerate its research and development, expand field trials, and refine its production processes to bring these advanced solutions to market swiftly.

In addition, the funding will support the scaling of manufacturing capabilities, ensuring that the bio-insecticides are accessible to a global audience facing the challenges of pest control and food security.

With a clear commitment to innovation and environmental stewardship, IBI-Ag is poised to transform the pest control landscape, offering a modern solution that upholds both the integrity of crop yields and the health of our planet.